Home
Membership
Join ACRO
Current Members
Initiatives
COVID-19
Decentralized Trials
Clinical Research Roundtables
CRO Forum
Risk-Based Quality Management
Advocacy
US Legislation & Regulation
EU Legislation & Regulation
Global Data Protection & Privacy
Addressing Industry Pain Points
CFO Roundtable
About
Facts & Figures on Clinical Research
Our Mission
News
Subscribe
Leadership
Contact Us
Clinical Trial Resources for Patients
CRO Forum
Federal Institute for Drugs and Medical Devices Guidance: Supplementary Recommendations to EU Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic (Version 3.0)
May 27, 2020
By
Katie Schneider
Previous Article
European Medicines Agency Report: Treatments and vaccines for COVID-19
Next Article
Food and Drug Administration Guidance: FDA Combatting COVID-19 with Medical Devices